Skip to main content
. 2018 Nov 12;18:1100. doi: 10.1186/s12885-018-5002-5

Fig. 1.

Fig. 1

Estimated proportion of adults with B-precursor ALL tested for MRD amongst clinicians who test for MRD. Footnote: ALL, acute lymphoblastic leukemia; CR1, first complete remission; CR2+, second complete remission or later; MRD, minimal residual disease